background
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
viral
pathogen
caus
sever
morbid
mortal
date
approv
licens
vaccin
antivir
medicin
use
treat
merscovinfect
patient
analyz
antivir
activ
resveratrol
natur
compound
found
grape
seed
skin
red
wine
merscov
infect
method
perform
mtt
neutral
red
uptak
assay
assess
surviv
rate
mersinfect
vero
cell
addit
quantit
pcr
western
blot
immunofluoresc
assay
determin
intracellular
viral
rna
protein
express
viral
product
util
plaqu
assay
confirm
antivir
properti
resveratrol
merscov
also
found
express
nucleocapsid
n
protein
essenti
merscov
replic
decreas
resveratrol
treatment
furthermor
resveratrol
downregul
apoptosi
induc
merscov
vitro
consecut
administr
resveratrol
abl
reduc
concentr
resveratrol
achiev
inhibitori
effect
merscov
studi
first
demonstr
resveratrol
potent
antim
agent
vitro
perceiv
resveratrol
potenti
antivir
agent
merscov
infect
near
futur
middl
east
respiratori
syndrom
mer
viral
respiratori
ill
caus
novel
coronaviru
merscov
identifi
saudi
arabia
decemb
mortal
rate
mer
patient
death
confirm
case
still
effect
antim
medicin
vaccin
commerci
avail
market
one
previou
studi
show
stilben
deriv
could
contain
antivir
activ
sever
acut
respiratori
syndrom
coronaviru
sarscov
result
test
whether
natur
stilben
deriv
resveratrol
inhibit
merscov
infect
studi
resveratrol
exist
wide
differ
plant
includ
grape
viti
vinifera
huzhang
polygonum
cuspidatum
cranberri
vaccinium
macrocarpon
past
resveratrol
demonstr
decreas
product
nitric
oxid
tissu
therebi
reduc
inflamm
resveratrol
also
act
antioxid
remov
free
radic
thu
restrain
tumor
growth
even
agerel
diseas
resveratrol
also
inhibit
signal
pathway
mtor
signal
hedgehog
signal
pathway
furthermor
resveratrol
reportedli
constrain
infect
caus
multipl
pathogen
helicobact
pylori
staphylococcu
aureu
toxoplasma
gondii
interestingli
resveratrol
demonstr
exert
antivir
effect
variou
viral
infect
includ
epsteinbarr
viru
ebv
enteroviru
herp
simplex
viru
hsv
well
respiratori
viral
infect
caus
influenza
respiratori
syncyti
viru
rsv
rhinoviru
howev
remain
unknown
whether
resveratrol
inhibit
merscov
infect
studi
evalu
antivir
effect
resveratrol
merscov
vitro
model
vero
cell
number
plant
cultur
plate
fetal
bovin
serum
fb
dmem
overnight
viral
infect
merscov
dilut
multipl
infect
moi
fbsdmem
replac
cultur
media
plate
mtt
bromid
reduc
formazan
purpl
color
cellular
oxidoreductas
indic
access
cell
metabol
briefli
vero
cell
cultur
well
plate
overnight
administr
viru
resveratrol
hour
incub
supernat
replac
new
cultur
medium
add
mgml
mtt
solut
well
plate
incub
hour
remov
mttcontain
medium
extract
formazan
mtt
solvent
consist
mm
hcl
nondet
isopropanol
follow
measur
level
purpl
formazan
elisa
reader
spectramax
plu
molecular
usa
wavelength
nm
readout
obtain
mtt
assay
normal
valu
uninfect
cell
valu
set
cell
cultur
plate
infect
viru
without
treatment
resveratrol
hour
perform
nru
assay
cultur
medium
remov
well
ad
wv
neutral
red
dmem
follow
incub
plate
co
hour
neutral
reddmem
remov
plate
wash
twice
pb
neutral
red
dye
extract
sorensen
citrat
buffer
plate
gentli
shaken
min
recov
neutral
red
dye
quantifi
elisa
reader
spectramax
plu
molecular
usa
wavelength
nm
result
obtain
normal
averag
readout
tissu
control
group
cell
viabil
set
vero
cell
plant
well
plate
overnight
conduct
plaqu
assay
viral
sampl
serial
dilut
mem
ad
cell
cell
incub
viral
sampl
one
hour
rock
plate
everi
min
incub
inoculum
remov
cell
wash
pb
mem
contain
agaros
ad
cell
overlay
medium
plate
incub
co
day
overlay
medium
solidifi
fix
directli
crystal
violet
solut
count
plaqu
vero
cell
seed
chamber
slide
infect
cell
treat
without
resveratrol
first
fix
paraformaldehyd
minut
permeabl
triton
min
minut
block
bsa
cell
immunostain
antimerscov
n
antibodi
sino
biolog
inc
china
dilut
overnight
three
wash
pb
cell
incub
dilut
alex
antirabbit
secondari
antibodi
thermo
fisher
usa
hour
cell
wash
three
time
pb
dapi
ad
second
wash
mer
nucleocapsid
express
examin
confoc
microscop
zeiss
germani
intracellular
stain
mer
nucleocapsid
protein
protocol
similar
immunofluoresc
assay
confoc
microscop
except
block
buffer
hors
serum
pbstriton
secondari
antibodi
irdy
dilut
pb
total
rna
sampl
vero
cell
without
mer
infect
isol
rneasi
mini
kit
germani
accord
manufactur
instruct
revers
transcript
pcr
amplif
carri
univers
onestep
rtqpcr
kit
usa
accord
manufactur
instruct
realtim
pcr
conduct
use
realtim
pcr
system
usa
along
follow
primer
pair
gapdhf
gapdhr
merscovf
actactcccatttcgtcag
merscovr
mer
rna
level
defin
viral
yield
l
normal
gapdh
rna
level
rel
compar
merscov
group
hpi
respect
rel
rna
level
investig
antimerscov
effect
resveratrol
directli
treat
merscov
infect
vero
cell
differ
concentr
resveratrol
cell
infect
merscov
moi
hour
imag
cellular
morpholog
via
microscopi
measur
cell
prolifer
mtt
assay
cell
viabil
neutral
red
uptak
nru
assay
cytotox
level
lactat
dehydrogenas
ldh
assay
resveratrol
seem
allevi
monolay
destruct
vero
cell
infect
merscov
fig
result
mtt
assay
fig
nru
assay
fig
show
resveratrol
reduc
cell
death
induc
merscov
infect
concentr
rang
also
resveratroltr
group
reveal
less
cytotox
ldh
assay
merscov
infect
fig
cytotox
profil
correl
well
cell
prolifer
cell
viabil
assay
determin
observ
antivir
effect
resveratrol
due
cytotox
perform
ldh
assay
resveratrol
treatment
figur
show
resveratrol
caus
limit
cytotox
vero
cell
even
highest
concentr
cytotox
consist
cytotox
merscovinfect
cell
reduc
resveratrol
treatment
approxim
fig
therefor
conclud
resveratrol
reduc
cell
death
caus
merscov
infect
determin
resveratrol
directli
inhibit
merscov
infect
assess
effect
resveratrol
merscov
viral
product
rna
level
collect
cell
sampl
without
viral
infect
resveratrol
treatment
hour
postinfect
hpi
extract
total
rna
subject
quantit
realtim
pcr
compar
rel
merscov
rna
level
shown
fig
merscov
rna
level
resveratroltr
cell
concentr
significantli
lower
merscovinfect
cell
hpi
howev
inhibitori
effect
low
concentr
resveratrol
includ
diminish
hpi
data
suggest
resveratrol
treatment
suppress
merscov
rna
replic
although
requir
rel
high
concentr
resveratrol
deliv
persist
antivir
effect
next
determin
infecti
titer
merscov
resveratrol
treatment
plaqu
reduct
assay
data
fig
show
mer
titer
significantli
reduc
resveratrol
treatment
respect
hpi
result
consist
obtain
quantit
realtim
pcr
hpi
summari
find
indic
treatment
cell
resveratrol
reduc
merscov
rna
level
infecti
titer
presum
account
observ
decreas
cell
death
previou
studi
shown
resveratrol
exert
antivir
activ
block
pathway
suggest
resveratrol
broad
spectrum
antivir
effect
downregul
inflammatori
signal
transduct
determin
whether
resveratrol
inhibit
entri
postentri
step
merscov
infect
ad
resveratrol
togeth
merscov
immedi
hour
infect
initi
fig
b
measur
cell
prolifer
fig
determin
viral
titer
supernat
fig
result
demonstr
even
resveratrol
given
merscov
infect
still
reduc
viral
titer
observ
made
cell
prolifer
viral
titer
measur
suggest
resveratrol
inhibit
merscov
infect
entri
corrobor
find
stain
nuclecapsid
n
protein
merscov
resveratrol
treatment
hpi
visual
n
protein
distribut
confoc
microscopi
imag
shown
fig
demonstr
resveratrol
elimin
n
protein
fluoresc
signal
compar
control
group
resveratrol
exhibit
limit
decreas
n
protein
signal
order
elucid
whether
strength
n
protein
signal
correl
concentr
resveratrol
perform
intracellular
stain
n
protein
cell
cultur
multipl
well
plate
mersinfect
vero
cell
fix
permeabl
facilit
antin
primari
antibodi
access
treat
resveratrol
hour
follow
paraformaldehyd
fixat
immunofluoresc
assay
nucleocapsid
express
examin
confoc
microscop
magnif
dapi
use
nucleu
stain
b
intracellular
stain
mer
nucleocapsid
express
visual
clx
imag
system
c
quantif
result
fluoresc
intens
mer
nucleocapsid
protein
determin
clx
imag
softwar
target
protein
quantifi
strength
fluoresc
licor
imag
system
fig
c
result
show
resveratrol
remark
inhibit
mer
nucleocapsid
protein
translat
dosedepend
manner
especi
concentr
apoptosi
differ
tissu
merscov
infect
wide
document
therefor
test
whether
resveratrol
abl
reduc
apoptosi
induc
merscov
due
cleavag
caspas
indic
apoptosi
reportedli
elev
merscov
infect
collect
cell
lysat
merscov
infect
resveratrol
treatment
hpi
conduct
western
blot
measur
caspas
cleavag
level
result
fig
show
protein
express
cleav
caspas
significantli
increas
merscov
infect
confirm
merscov
could
caus
cellular
apoptosi
interestingli
resveratrol
ad
level
caspas
cleavag
decreas
concentr
resveratrol
went
higher
level
caspas
cleavag
decreas
dosedepend
manner
fig
result
suggest
resveratrol
reduc
merscovmedi
apoptosi
notabl
resveratrol
lower
caspas
cleavag
level
fig
c
given
cytotox
resveratrol
result
expect
qpcr
fig
western
blot
result
fig
notic
resveratrol
appear
inhibit
merscov
within
hour
lost
effect
hpi
loss
inhibitori
effect
hr
could
due
degrad
resveratrol
media
long
period
incub
given
high
dosag
resveratrol
still
cytotox
fig
lower
dosag
desir
treat
mersinfect
patient
clinic
explor
possibl
util
resveratrol
lower
dosag
ad
resveratrol
consecut
everi
hr
mersinfect
cell
lower
concentr
evalu
cell
prolifer
cell
viabil
cytotox
fig
interestingli
consecut
addit
resveratrol
partial
rescu
merscovinduc
cell
death
fig
lower
product
infecti
merscov
approxim
tenfold
fig
indic
resveratrol
inhibit
merscov
administr
lower
dosag
given
consecut
furthermor
test
effect
resveratrol
anoth
emerg
positivesens
rna
viru
chikungunya
viru
shown
fig
resveratrol
inhibit
merscov
viral
product
also
reduc
product
chikungunya
viru
concentr
altogeth
data
suggest
resveratrol
might
lead
candid
preclin
assess
antivir
activ
merscov
addit
emerg
rna
virus
emerg
human
viral
pathogen
merscov
infect
caus
devast
diseas
due
high
mortal
therefor
urgent
develop
vaccin
therapeut
outbreak
sever
acut
respiratori
syndrom
sar
sever
antimicrobi
agent
use
treat
sarsinfect
patient
includ
ribavirin
lopinavirritonavir
type
interferon
howev
medic
regim
show
signific
efficaci
sar
came
along
side
effect
renal
dysfunct
hemolyt
anemia
caus
ribavirin
merscov
epidem
treatment
provid
none
limit
improv
surviv
patient
efficaci
remain
unclear
result
effect
remedi
candid
merscov
epidem
studi
report
antimerscov
activ
resveratrol
vitro
provid
evid
support
detail
examin
potenti
clinic
benefit
resveratrol
merscov
infect
acknowledg
necessari
valid
antim
efficaci
resveratrol
vivo
howev
experiment
anim
includ
rabbit
mice
ferret
asymptomat
mer
infect
sinc
dipeptidyl
peptidas
crucial
receptor
merscov
hypothes
human
express
mice
could
suitabl
model
examin
antim
activ
resveratrol
futur
resveratrol
minor
cytotox
even
high
concentr
neglect
compar
toxic
level
caus
merscov
infect
much
greater
resveratrol
consid
robust
cell
death
caus
merscov
think
resveratrol
treatment
remain
viabl
therapeut
strategi
studi
shown
resveratrol
given
either
high
dosag
rel
low
concentr
consecut
treat
merscovinfect
cell
term
possibl
antivir
mechan
resveratrol
resveratrol
report
activ
signal
pathway
promot
cell
prolifer
enhanc
signal
relat
cellular
surviv
dna
repair
respons
dna
damag
hand
resveratrol
could
counteract
merscovinduc
apoptosi
downregul
signal
addit
merscov
infect
could
lead
product
inflammatori
cytokin
wherea
resveratrol
may
reduc
inflamm
interf
pathway
studi
level
cleav
caspas
reduc
reseveratol
merscov
infect
chang
may
result
direct
inhibit
caspas
cleavag
resvert
cell
surviv
reduct
virusinduc
apoptosi
resveratrol
inhibit
upstream
event
requir
caspas
cleavag
exact
mechan
need
investig
observ
antimerscov
effect
appear
collect
result
promot
cell
surviv
reduct
virusinduc
apoptosi
resveratrol
studi
firmli
found
resveratrol
alon
inhibit
merscov
infect
futur
studi
evalu
potenti
synergi
resveratrol
potenti
antimerscov
compound
treat
merscov
infect
abbrevi
extracellular
signalregul
protein
kinas
ldh
lactat
dehydrogenas
merscov
middl
east
respiratori
syndrom
coronaviru
nuclear
factorkappa
b
nru
neutral
red
uptak
sar
sever
acut
respiratori
syndrom
research
receiv
specif
grant
fund
agenc
public
commerci
notforprofit
sector
data
support
find
contain
within
manuscript
author
contribut
ccl
ttw
design
studi
interpret
result
wrote
manuscript
scl
perform
experi
particip
draft
manuscript
cth
prepar
manuscript
whc
sl
provid
necessari
experiment
materi
studi
author
read
approv
final
manuscript
author
declar
compet
interest
